Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (11): 53-58.doi: 10.6040/j.issn.1671-7554.0.2019.1426

Previous Articles     Next Articles

Effects of propofol on proliferation, migration and expressions of Wnt1 and β-catenin in colon cancer cells

HONG Jiageng1, NIE Yangyang1, SU Guoqiang2   

  1. 1. Department of Anesthesiology;
    2. Department Ⅲ of Gastrointestinal Surgery, First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China
  • Published:2020-11-04

PDF (PC)

271

Abstract: Objective To investigate the effects of propofol on the proliferation, migration and mRNA expressions of Wnt1 and β-catenin in human colon cancer cells with different degrees of differentiation in vitro. Methods Two human colon cancer cell lines Caco-2(highly differentiated)and LoVo(lowly differentiated)were selected and assigned to P0(0 μg/mL), P6.25(6.25 μg/mL), P25(25 μg/mL), and P100(100 μg/mL)groups according to different concentrations of propofol. The effects of propofol on the proliferation and migration of Caco-2 and LoVo cells were detected with CCK-8 and Transwell migration assay, respectively. The sensitivity of cells to different concentrations of propofol was compared. The mRNA expressions of Wnt1 and β-catenin in Caco-2 and LoVo cells were determined with real-time PCR. Results The CCK-8 results showed significant difference in Caco-2 viability between P100 group treated for 24 h and P0 group(P<0.001), and between P25 group treated for 48 h and P0 group(P<0.05); and significant difference in LoVo viability between P100 group treated for 24 h and P0 group(P<0.05 ), and between P25 group treated for 48 h and P0 group(P<0.05). Transwell migration results showed significant difference in OD570 nm value in Caco-2 cell line between P6.25, P25, P100 groups and P0 group(P<0.001); and in LoVo cell line between P25, P100 groups and P0 group(P<0.001). Real-time PCR results showed significant difference in Wnt1 mRNA expression in Caco-2 cell line between P25, P100 groups and P0 group(P<0.05), in LoVo cell line between P25, P100 groups and P0 group(P<0.001); and significant difference in β-catenin mRNA expression in Caco-2 cell line between P25, P100 groups and P0 group(P<0.001), and in LoVo cell line between P100 group and P0 group(P<0.001). Conclusion Propofol inhibits the proliferation and migration of human colon cancer cells Caco-2 and LoVo in a dose- and time-dependent manner. Caco-2 is more sensitive to the inhibitory effects of propofol than LoVo.

Key words: Propofol, Colorectal cancer, Proliferation, Migration, Wnt/β-catenin signaling pathway

CLC Number: 

  • R735
[1] Sneyd JR. Recent advances in intravenous anaesthesia[J]. Br J Anaesth, 2004, 93(5): 725-736.
[2] Vasileiou I, Xanthos T, Koudouna E, et al. Propofol: a review of its non-anaesthetic effects[J]. Eur J Pharmacol, 2009, 605(1-3): 1-8.
[3] Wang J, Cheng CS, Lu Y, et al. Novel findings of anti-cancer property of propofol[J]. Anti-cancer Agents Med Chem, 2018, 18(2): 156-165.
[4] Zhang D, Zhou XH, Zhang J, et al. Propofol promotes cell apoptosis via inhibiting HOTAIR mediated mTOR pathway in cervical cancer[J]. Biochem Biophys Res Commun, 2015, 468(4): 561-567.
[5] Xu YB, Jiang W, Zhao FR, et al. Propofol suppresses invasion and induces apoptosis of osteosarcoma cell in vitro via downregulation of TGF-beta1 expression[J]. Eur Rev Med Pharmacol Sci, 2016, 20(7): 1430-1435.
[6] Huang X, Teng Y, Yang H, et al. Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-kappaB signal[J]. Braz J Med Biol Res, 2016, 49(12): e5717. doi:10.1590/1414-431x20165717.
[7] Bahrami A, Amerizadeh F, Shahidsales S, et al. Therapeutic potential of targeting wnt/beta-catenin pathway in treatment of colorectal cancer: rational and progress[J]. J Cell Biochem, 2017, 118(8): 1979-1983.
[8] Novellasdemunt L, Antas P, Li VS. Targeting wnt signaling in colorectal cancer. A review in the theme: cell signaling: proteins, pathways and mechanisms[J]. Am J Physiol Cell Physiol, 2015, 309(8): 511-521.
[9] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[10] Lee JW, Shahzad MM, Lin YG, et al. Surgical stress promotes tumor growth in ovarian carcinoma[J]. Clin Cancer Res, 2009, 15(8): 2695-2702.
[11] 周荻, 缪长虹. 手术对肿瘤转移的影响以及麻醉对策[J]. 国际麻醉学与复苏杂志, 2013, 34(9): 808-811,815. ZHOU Di, MIAO Changhong. Effect of surgery on cancer recurrence and anaesthetic strategy[J]. International Journal of Anesthesiology and Resuscitation, 2013, 34(9): 808-811, 815.
[12] Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence[J]. J Transl Med, 2018, 16(1): 8. doi:10.1186/s12967-018-1389-7.
[13] Jiang S, Liu Y, Huang L, et al. Effects of propofol on cancer development and chemotherapy: potential mechanisms[J]. Eur J Pharmacol, 2018, 831(15): 46-51.
[14] Song J, Shen Y, Zhang J, et al. Mini profile of potential anticancer properties of propofol[J]. PLoS One, 2014, 9(12): e114440. doi: 10.1371/journal.pone.0114440.
[15] Gao X, Mi Y, Guo N, et al. The mechanism of propofol in cancer development: an updated review[J]. Asia Pac J Clin Oncol, 2020, 16(2): e3-e11. doi: 10.1111/ajco.13301.
[16] Kim R. Anesthetic technique and cancer recurrence in oncologic surgery: unraveling the puzzle[J]. Cancer Metastasis Rev, 2017, 36(1): 159-177.
[17] Bajwa SJ, Anand S, Kaur G. Anesthesia and cancer recurrences: the current knowledge and evidence[J]. J Cancer Res Ther, 2015, 11(3): 528-534.
[18] Heaney A, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis?[J]. Br J Anaesth, 2012, 109(Suppl 1): i17-i28. doi:10.1093/bja/aes421
[19] Xu YB, Du QH, Zhang MY, et al. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells[J]. Eur Rev Med Pharmacol Sci, 2013, 17(18): 2486-2494.
[20] Peng Z, Zhang Y. Propofol inhibits proliferation and accelerates apoptosis of human gastric cancer cells by regulation of microRNA-451 and MMP-2 expression[J]. Genet Mol Res, 2016, 15(2): gmr7078. doi:10.4238/gmr.15027078.
[21] Yufeng Miao, Youwei Zhang, Haijun Wan, et al. GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells[J]. Biomed Pharmacother, 2010, 64(9): 583-588.
[22] 余海燕, 刘德生, 王云. 丙泊酚对结直肠癌细胞生物学行为的影响[J]. 中国病理生理杂志, 2018, 34(2): 245-250. YU Haiyan, LIU Desheng, WAGN Yun. Effects of propofol on biological characteristics of colorectal cancer cells[J]. Chinese Journal of Pathophysiology, 2018, 34(2): 245-250.
[23] Tavare AN, Perry NJ, Benzonana LL, et al. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents[J]. Int J Cancer, 2012, 130(6): 1237-1250.
[24] Clevers H, Loh KM, Nusse R. Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control[J]. Science, 2014, 346(6205): 1248012. doi: 10.1126/science.1248012.
[25] Vijayakumar S, Liu G, Rus IA, et al. High-frequency canonical wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A[J]. Cancer Cell, 2011, 19(5): 601-612.
[26] Yang Y, Yang JJ, Tao H, et al. New perspectives on beta-catenin control of cell fate and proliferation in colon cancer[J]. Food Chem Toxicol, 2014, 74:14-19. doi: 10.1016/j.fct.2014.08.013.
[27] Laezza C, Dalessandro A, Paladino S, et al. Anandamide inhibits the wnt/β-catenin signaling pathway in human breast cancer MDA MB 231 cells[J]. Eur J cancer, 2012, 48(16): 3112-3122.
[1] WANG Xiao-Lei, ZHANG Hai-Thao, ZHANG Hui, GUO Cheng-Hao. Protective effects of shuxuening injecta on vascular  endothelial  cell injury in vitro due to iodine excesses [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 38-.
[2] SUN Yifeng, GAO Yu, LIANG Yongyuan, GAO Yang. Expression of CPLX2 and its in vitro effects on the proliferation migration and invasion of hepatocellular carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 34-39.
[3] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38-46.
[4] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32-37.
[5] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7-14.
[6] LI Changda, SHI Yongjun, LIN Yanliang. Effects of 27-hydroxycholesterol and cholesterol on the proliferation of esophageal squamous cell carcinoma in nude mice and human esophageal carcinoma cells(ECA109) [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 45-52.
[7] WANG Kaimin, TAN Juanjuan, YAN Zhiqiang, LI Zhiqiang. Effects of Sirtuin on hypoxia-induced proliferation of human umbilical cord-derived mesenchymal stem cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 23-30.
[8] SHI Peikun, ZENG Beini, WU Weifang, HU Xiaoyan, MA Tianjia, ZHOU Yabin. Expression and role of Keap1 in renal cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 94-99.
[9] SUN Zeyu, CHEN Ying, LIN Jiaxiang, LIU Juan, ZHAO Weiming. Influence of inositol polyphosphate-4-phosphatase type II on the proliferation and apoptosis of cervical cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 1-6.
[10] WANG Bishi, SHAN Junqi, HOU Qingsheng, GONG Weipeng, ZHU Zhenyu, GUO Hongliang. Effort of CD11b+ / CD66b- phenotype myeloid cells on the progression of colon cancer and liver metastasis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 41-45.
[11] WANG Tiantian, CHEN Jie. Expression and clinical significance of EFEMP2 in endometrial cancer tissues and cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 52-58.
[12] LU Heng, LIU Yanguo, LI Shuguang, CHEN Xiaokang, TIAN Qi, YI Cuihua, WANG Xiuwen. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 33-38.
[13] ZHAO Lu, JIAO Jun, ZHANG Teng, JIAO Xinlin, CUI Baoxia. Expression of LXRα in ovarian carcinoma and effects of T0901317 on SKOV3 cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 49-53.
[14] TIAN Siqi, LIU Riqiang, YANG Ning, WEI Wei, YANG Huawei. Effect of expression of ribosomal protein S6 Kinase 4 variants on the proliferation of breast cancer cell MDA-MB-231 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 32-36.
[15] WANG Wei, CAO Yushan, SUN Daquan, HUANG Xiaoqiong, XU Guoqiang. Role of human TIMP-2 protein in the migration and invasion of hepatocellular carcinoma cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 11-17.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd